5.3.1.4. Other retrovirals
Restrictions:
Restricted for specialist use in adults and adolescents (weighing at least 35kg) at high risk of sexually acquired HIV who are eligible for pre-exposure prophylaxis (PrEP), including oral PrEP, but for whom oral PrEP is not appropriate to meet their HIV prevention needs. Use in accordance with national protocol (under development).
Restrictions:
The use in combination with other antiretroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age is restricted to use by HIV specialists.
Restrictions:
Restricted to use by HIV specialists in patients with triple-class resistant HIV-1 infection or in combination with other treatments in adult patients who are intolerant or resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors (PIs) or when these options are compromised due to drug-drug interactions.


